查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1532834

免疫疗法药物市场，按类型、按产品、按分布、按给药途径、最终用户、按国家和地区 - 2024-2032 年行业分析、市场规模、市场份额和预测

Immunotherapy Drugs Market, By Type, By Product, By Distribution, By Route of Administration, By End User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 381 Pages | 商品交期: 2-3个工作天内

价格

报告要点

2023年免疫治疗药物市场规模为2,788.9778亿美元，2024年至2032年复合年增长率为14.92%。

免疫治疗药物市场-市场动态

全球癌症病例数不断增加

癌症发生率的不断上升推动了对有效治疗的需求。免疫疗法利用人体的免疫系统来对抗癌症，正在成为一种流行的选择，导致这些药物的市场不断扩大。对新的、更有效的治疗方法的需求刺激了研发 (R&D) 的投资。这包括资助临床试验、探索新的免疫疗法和开发新药。公司正在扩大产品组合併进入新市场，以满足不断增长的需求。这包括开发针对不同类型癌症的疗法以及创建增强免疫疗法有效性的组合疗法。例如，为了创造新颖的、潜在有效的癌症药物，伦敦癌症研究所的研究人员正在与小分子免疫肿瘤学企业 NeoPhore 合作，以鑑定新抗原。作为新策略研究合作的一部分，Chris Lord 教授领导下的 ICR 团队将在实验室中研究 NeoPhore 抑制剂如何影响肿瘤。

免疫治疗药物市场 - 关键见解

根据我们的研究分析师分享的分析，预计全球市场在预测期内（2024-2032 年）每年将以 14.92% 左右的复合年增长率成长

根据类型细分，预计单株抗体将在 2023 年呈现最大市场份额

从产品细分来看，生物製剂是2023年的主导类型

从分销细分来看，零售药局是2023年的主导类型

根据最终用户细分，医院是 2023 年的主导类型

按地区划分，北美是 2023 年的主要收入来源

免疫治疗药物市场-細項分析：

全球免疫疗法药物市场根据类型、产品、分销、给药途径、最终用户和地区进行细分。

根据产品类型，市场分为六类：单株抗体、疫苗、检查点抑制剂、非特异性免疫疗法、溶瘤病毒免疫疗法和T细胞疗法。 mAb 旨在特异性结合某些抗原，例如癌细胞、病原体或发炎细胞表面的蛋白质。这种标靶最大限度地减少对健康细胞和组织的损害，使治疗更有效并减少副作用。它们提供高度特异性的治疗，有助于准确诊断和治疗疾病。

根据应用，市场分为五类：医院、诊所、癌症研究中心、门诊手术中心和家庭护理机构。免疫疗法药物旨在增强或恢復人体自然免疫系统识别和破坏癌细胞的能力。与化疗和放疗等传统治疗方法相比，这种有针对性的方法更有效，对健康细胞的损害也更小。免疫疗法可以根据癌症的特定特征针对个别患者进行客製化。这种个人化的方法可以改善治疗效果并减少副作用。

免疫疗法药物市场 - 地理洞察

免疫治疗药物市场是製药业中一个快速成长的领域，北美地区的活动和发展都非常活跃。美国因其先进的医疗基础设施、大量的研发投资和高癌症盛行率而成为免疫治疗市场的主要参与者。 FDA 对多种免疫疗法药物的批准以及生物技术和製药公司的强大影响力推动了成长。德国、法国和英国等国家因其强大的医疗保健系统和活跃的研究机构而在免疫治疗市场中占据主导地位。欧洲药品管理局 (EMA) 在药品审批和市场准入方面发挥着至关重要的作用。此外，在癌症发病率上升和医疗基础设施改善的推动下，印度是一个新兴市场，对免疫疗法的兴趣日益浓厚。 2023年10月，印度与美国食品药物管理局对应的中央药品标准控制组织使NexCAR19成为印度首个核准的CAR-T细胞疗法。

免疫疗法药物市场-竞争格局：

免疫疗法药物市场的领导者包括百时美施贵宝、默克、罗氏、辉瑞、诺华和安进等。点抑制剂、 CAR-T 细胞疗法和其他创新疗法。默沙东是PD-1/PD-L1抑制剂的市场领导者，拥有丰富的临床试验资料和广泛的适应症。辉瑞在免疫治疗和标靶治疗方面拥有专业知识，并且拥有强大的临床研究。 2024 年 2 月，佛罗里达大学健康癌症中心的研究人员团队开发了一种首创的化合物，可以为使用免疫疗法治疗各种类型的癌症开闢一条新途径。此外，加州THOUSAND OAKS 和新泽西州KENILWORTH 宣布开展一项癌症免疫治疗合作，以支持一项1b/3 期研究，该研究调查BLINCYTO 联合KEYTRUDA 治疗瀰漫性大B 细胞淋巴瘤(DLBCL) 患者，DLBCL 是最常见的疾病非何杰金氏淋巴瘤（NHL）的类型。该市场的特点是快速创新，重点是开发新的、更有效的疗法，包括联合疗法和个人化治疗。

最新进展：

2024年4月，BostonGene和佐贺大学宣布启动一项合作，旨在发现晚期非小细胞肺癌（NSCLC）患者免疫疗法（IO）治疗反应和治疗相关毒性的生物标记。 EGFR-TKI 治疗有效针对 EGFR 突变阳性 NSCLC。儘管如此，获得性抗药性通常会导致 1 至 2 年内復发，这对治疗后优化提出了挑战。

2022 年 6 月，马剋癌症研究基金会扩大了与约翰霍普金斯大学的合作关係，以加速突破性的免疫疗法研究。与 Bloomberg~Kimmel 研究所的合作使我们能够开发用于拯救生命所需的癌症免疫治疗的下一代基因组学和成像平台。

目录

第一章：免疫治疗药物市场概述

  • 研究范围
  • 市场预估年份

第 2 章：执行摘要

  • 市场片段
    • 按类型分類的免疫治疗药物市场片段
    • 免疫治疗药物市场片段（按产品）
    • 免疫治疗药物市场片段（依分布）
    • 按给药途径分類的免疫治疗药物市场片段
    • 最终用户的免疫治疗药物市场片段
    • 按国家/地区分類的免疫治疗药物市场片段
    • 按地区分類的免疫疗法药物市场片段
  • 竞争洞察

第 3 章：免疫治疗药物主要市场趋势

  • 免疫治疗药物市场驱动因素
    • 市场驱动因素的影响分析
  • 免疫治疗药物市场限制
    • 市场限制影响分析
  • 免疫治疗药物市场机会
  • 免疫疗法药物市场未来趋势

第 4 章：免疫治疗药物产业研究

  • PEST分析
  • 波特五力分析
  • 成长前景图
  • 规范架构分析

第 5 章：免疫治疗药物市场：COVID-19 影响分析

  • COVID-19 之前的影响分析
  • COVID-19 后影响分析
    • 表现最佳的市场区隔
    • 边际增长部分
    • 最鬆散的部分
    • 边际损失部分

第 6 章：免疫治疗药物市场格局

  • 2023 年免疫治疗药物市场占有率分析
  • 按主要製造商分類的故障数据
    • 既定玩家分析
    • 新兴玩家分析

第 7 章：免疫治疗药物市场 - 按类型

  • 概述
    • 按类型分類的细分市场占有率分析
    • 单株抗体
    • 疫苗
    • 检查点抑制剂
    • 非特异性免疫疗法
    • 溶瘤病毒免疫疗法
    • T细胞疗法

第 8 章：免疫治疗药物市场 - 副产品

  • 概述
    • 按产品分類的细分市场占有率分析
    • 生物製剂
      • 重组蛋白
      • 抗体
    • 小分子

第 9 章：免疫治疗药物市场 - 按分布

  • 概述
    • 按分布分類的细分市场占有率分析
    • 医院药房
    • 零售药局
    • 网路药局

第 10 章：免疫治疗药物市场 - 按给药途径

  • 概述
    • 按产品分類的细分市场占有率分析
    • 静脉注射 (IV)
    • 皮下
    • 口服
    • 肌肉注射

第 11 章：免疫治疗药物市场 - 按最终用户

  • 概述
    • 按最终用户分類的细分市场占有率分析
    • 医院
    • 诊所
    • 癌症研究中心
    • 门诊手术中心
    • 家庭护理设置

第 12 章：免疫治疗药物市场 - 按地理位置

  • 介绍
    • 按地理位置分類的细分市场占有率分析
  • 北美洲
    • 概述
    • 北美免疫疗法药物主要製造商
    • 北美市场规模和预测（按国家）
    • 北美市场规模和预测（按类型）
    • 北美市场规模和预测（按产品）
    • 北美市场规模和预测（按分布）
    • 北美市场规模与预测（按管理途径）
    • 北美市场规模和预测（按最终用户）
    • 我们
    • 加拿大
  • 欧洲
    • 概述
    • 欧洲免疫疗法药物主要製造商
    • 欧洲市场规模和预测（按国家）
    • 欧洲市场规模与预测（按类型）
    • 欧洲市场规模与预测（按产品）
    • 欧洲市场规模与预测（按分布）
    • 欧洲市场规模与预测（按管理途径）
    • 欧洲市场规模和预测（按最终用户）
    • 德国
    • 义大利
    • 英国
    • 法国
    • 俄罗斯
    • 荷兰
    • 瑞典
    • 波兰
    • 欧洲其他地区
  • 亚太地区 (APAC)
    • 概述
    • 亚太地区免疫治疗药物主要製造商
    • 亚太地区市场规模与预测（按国家）
    • 亚太地区市场规模与预测（按类型）
    • 亚太地区市场规模与预测（按产品）
    • 亚太地区市场规模与预测（按分布）
    • 亚太地区市场规模与预测（依管理途径）
    • 亚太地区市场规模和预测（按最终用户）
    • 印度
    • 中国
    • 日本
    • 韩国
    • 澳洲
    • 泰国
    • 印尼
    • 菲律宾
    • 亚太地区其他地区
  • 拉丁美洲
    • 概述
    • 拉丁美洲免疫疗法药物主要製造商
    • 拉丁美洲市场规模与预测（按国家）
    • 拉丁美洲市场规模与预测（按类型）
    • 拉丁美洲市场规模与预测（按产品）
    • 拉丁美洲市场规模与预测（按分布）
    • 拉丁美洲市场规模与预测（按管理途径）
    • 拉丁美洲市场规模和预测（按最终用户）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥伦比亚
    • 拉丁美洲其他地区
  • 中东和非洲
    • 概述
    • 中东和非洲免疫疗法药物主要製造商
    • 中东和非洲市场规模及预测（按国家）
    • 中东和非洲市场规模及预测（按类型）
    • 中东和非洲市场规模及预测（按产品）
    • 中东和非洲市场规模及预测（按分布）
    • 中东和非洲市场规模及预测（按管理途径）
    • 中东和非洲市场规模及预测（按最终用户）
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 以色列
    • 土耳其
    • 阿尔及利亚
    • 埃及
    • MEA 的其余部分

第 13 章：主要供应商分析 - 免疫疗法药物产业

  • 竞争仪表板
  • 公司简介
    • Bristol-Myers Squibb
    • Merck & Co.
    • Roche
    • Pfizer
    • Novartis
    • Gilead Sciences
    • Amgen
    • Sanofi
    • Regeneron Pharmaceuticals
    • Bluebird Bio
    • Cellectis
    • Others

第 14 章：360 度分析师视角

第 15 章：附录

  • 研究方法
  • 参考
  • 缩写
  • 免责声明
  • 联络我们
Product Code: ANV3460

REPORT HIGHLIGHT

Immunotherapy Drugs Market size was valued at USD 278,897.78 million in 2023, expanding at a CAGR of 14.92% from 2024 to 2032.

The rising number of cancer cases worldwide is a major driver for the growth of immunotherapy drugs. Immunotherapies offer new hope for patients with various types of cancer. Continuous R&D in immunotherapy has led to the development of more effective and targeted therapies, including checkpoint inhibitors, CAR-T cell therapies, and monoclonal antibodies. However, some immunotherapies can cause severe side effects, such as cytokine release syndrome or autoimmune reactions, which need careful management. The production of some immunotherapy drugs, like CAR-T cell therapies, involves complex and costly manufacturing processes. Furthermore, strategic collaborations between pharmaceutical companies, research institutions, and biotech firms can accelerate the development of new therapies and expand market reach.

Immunotherapy Drugs Market- Market Dynamics

The increasing number of cancer cases worldwide

The growing incidence of cancer drives demand for effective treatments. Immunotherapy, which harnesses the body's immune system to fight cancer, is becoming a popular choice, leading to an increased market for these drugs. The need for new and more effective treatments spurs investment in research and development (R&D). This includes funding for clinical trials, exploring new immunotherapy approaches, and developing novel drugs. Companies are expanding their product portfolios and entering new markets to meet the growing demand. This includes developing therapies for different types of cancer and creating combination treatments that enhance the effectiveness of immunotherapies. For instance, To create novel, potentially effective cancer medications, researchers at The Institute of Cancer Research, London, are collaborating with NeoPhore, a small molecule immuno-oncology business, to identify neoantigens. An ICR team under the direction of Professor Chris Lord will examine how NeoPhore's inhibitors affect tumors in the lab as part of a new strategic research cooperation.

Immunotherapy Drugs Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 14.92% over the forecast period (2024-2032)

Based on type segmentation, Monoclonal Antibodies were predicted to show maximum market share in the year 2023

Based on product segmentation, Biologics was the leading type in 2023

Based on distribution segmentation, Retail Pharmacies was the leading type in 2023

Based on end-user segmentation, Hospitals was the leading type in 2023

based on region, North America was the leading revenue generator in 2023

Immunotherapy Drugs Market- Segmentation Analysis:

The Global Immunotherapy Drugs Market is segmented based on Type, Product, Distribution, Route of Administration, End User, and Region.

The market is divided into six categories based on product type: Monoclonal Antibodies, Vaccines, Checkpoint Inhibitors, Non-Specific Immunotherapies, Oncolytic Virus Immunotherapy, and T-Cell Therapy. mAbs are designed to bind specifically to certain antigens, such as proteins on the surface of cancer cells, pathogens, or inflammatory cells. This targeting minimizes damage to healthy cells and tissues, making treatments more effective and reducing side effects. They provide high specificity in treatment, which helps in accurately diagnosing and treating diseases.

The market is divided into five categories based on application: Hospitals, Clinics, Cancer Research Centers, Ambulatory Surgical Centers, and Homecare Settings. Immunotherapy drugs are designed to enhance or restore the body's natural immune system's ability to recognize and destroy cancer cells. This targeted approach can be more effective and less damaging to healthy cells compared to traditional treatments like chemotherapy and radiation. Immunotherapy can be tailored to individual patients based on the specific characteristics of their cancer. This personalized approach can improve treatment outcomes and reduce side effects.

Immunotherapy Drugs Market- Geographical Insights

The immunotherapy drugs market is a rapidly growing sector in the pharmaceutical industry, with significant activity and development occurring across North American regions. The U.S. is a major player in the immunotherapy market due to its advanced healthcare infrastructure, substantial R&D investments, and high prevalence of cancer. The FDA's approval of numerous immunotherapy drugs and the strong presence of biotech and pharmaceutical companies drive growth. Countries like Germany, France, and the UK are prominent in the immunotherapy market due to their strong healthcare systems and active research institutions. The European Medicines Agency (EMA) plays a crucial role in drug approvals and market access. Furthermore, India is an emerging market with growing interest in immunotherapy, driven by increasing cancer incidence and improving healthcare infrastructure. In October 2023, India's counterpart to the US Food and Drug Administration, the Central Drugs Standard Control Organization, made NexCAR19 India's first approved CAR-T cell therapy.

Immunotherapy Drugs Market- Competitive Landscape:

Leading players in the immunotherapy drugs market Bristol-Myers Squibb, Merck & Co., Roche, Pfizer, Novartis, and Amgen, etc. The immunotherapy drugs market is diverse and includes several key players across various segments, including monoclonal antibodies, checkpoint inhibitors, CAR-T cell therapies, and other innovative treatments. Merck & Co. is a market leader in PD-1/PD-L1 inhibitors, with extensive clinical trial data, and broad indications. Pfizer has expertise in both immunotherapy and targeted therapies and strong clinical research. In February 2024, A team of UF Health Cancer Center researchers developed a first-of-its-kind compound that could open a new avenue for using immunotherapy to treat various types of cancer. In addition, THOUSAND OAKS, Calif. and KENILWORTH, N.J., announced a cancer immunotherapy collaboration to support a Phase 1b/3 study investigating BLINCYTO in combination with KEYTRUDA in patients with diffuse large B-cell lymphoma (DLBCL), which is the most common type of non-Hodgkin lymphoma (NHL). The market is characterized by rapid innovation, with a focus on developing new and more effective therapies, including combination therapies and personalized treatments.

Recent Developments:

In April 2024, BostonGene and Saga University announced the launch of a collaboration aimed at discovering biomarkers for immunotherapy (IO) treatment response and treatment-related toxicity in advanced non-small cell lung cancer (NSCLC) patients. EGFR-TKI treatment effectively targets EGFR mutation-positive NSCLC. Still, acquired resistance often leads to recurrence within 1 to 2 years, presenting a challenge for post-treatment optimization.

In June 2022, The Mark Foundation for Cancer Research expanded its partnership with the Johns Hopkins University to accelerate groundbreaking immunotherapy research. The collaboration with the Bloomberg~Kimmel Institute allows us to develop the next-generation genomics and imaging platforms for cancer immunotherapy necessary to save lives.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL IMMUNOTHERAPY DRUGS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

Bristol-Myers Squibb

Merck & Co.

Roche

Pfizer

Novartis

Gilead Sciences

Amgen

Sanofi

Regeneron Pharmaceuticals

Bluebird Bio

Cellectis

Others

GLOBAL IMMUNOTHERAPY DRUGS MARKET, BY TYPE- MARKET ANALYSIS, 2019 - 2032

  • Monoclonal Antibodies
  • Vaccines
  • Checkpoint Inhibitors
  • Non-Specific Immunotherapies
  • Oncolytic Virus Immunotherapy
  • T-Cell Therapy

GLOBAL IMMUNOTHERAPY DRUGS MARKET, BY PRODUCT - MARKET ANALYSIS, 2019 - 2032

  • Biologics
  • Recombinant Proteins
  • Antibodies
  • Small Molecules

GLOBAL IMMUNOTHERAPY DRUGS MARKET, BY DISTRIBUTION- MARKET ANALYSIS, 2019 - 2032

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

GLOBAL IMMUNOTHERAPY DRUGS MARKET, BY ROUTE OF ADMINISTRATION- MARKET ANALYSIS, 2019 - 2032

  • Intravenous (IV)
  • Subcutaneous
  • Oral
  • Intramuscular

GLOBAL IMMUNOTHERAPY DRUGS MARKET, BY END-USER- MARKET ANALYSIS, 2019 - 2032

  • Hospitals
  • Clinics
  • Cancer Research Centers
  • Ambulatory Surgical Centers
  • Homecare Settings

GLOBAL IMMUNOTHERAPY DRUGS MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Immunotherapy Drugs Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Immunotherapy Drugs Market Snippet by Type
    • 2.1.2. Immunotherapy Drugs Market Snippet by Product
    • 2.1.3. Immunotherapy Drugs Market Snippet by Distribution
    • 2.1.4. Immunotherapy Drugs Market Snippet by Route of Administration
    • 2.1.5. Immunotherapy Drugs Market Snippet by End User
    • 2.1.6. Immunotherapy Drugs Market Snippet by Country
    • 2.1.7. Immunotherapy Drugs Market Snippet by Region
  • 2.2. Competitive Insights

3. Immunotherapy Drugs Key Market Trends

  • 3.1. Immunotherapy Drugs Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Immunotherapy Drugs Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Immunotherapy Drugs Market Opportunities
  • 3.4. Immunotherapy Drugs Market Future Trends

4. Immunotherapy Drugs Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Immunotherapy Drugs Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Immunotherapy Drugs Market Landscape

  • 6.1. Immunotherapy Drugs Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Immunotherapy Drugs Market - By Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Type, 2023 & 2032 (%)
    • 7.1.2. Monoclonal Antibodies
    • 7.1.3. Vaccines
    • 7.1.4. Checkpoint Inhibitors
    • 7.1.5. Non-Specific Immunotherapies
    • 7.1.6. Oncolytic Virus Immunotherapy
    • 7.1.7. T-Cell Therapy

8. Immunotherapy Drugs Market - By Product

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Product, 2023 & 2032 (%)
    • 8.1.2. Biologics
      • 8.1.2.1. Recombinant Proteins
      • 8.1.2.2. Antibodies
    • 8.1.3. Small Molecules

9. Immunotherapy Drugs Market - By Distribution

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Distribution, 2023 & 2032 (%)
    • 9.1.2. Hospital Pharmacies
    • 9.1.3. Retail Pharmacies
    • 9.1.4. Online Pharmacies

10. Immunotherapy Drugs Market - By Route of Administration

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By Product, 2023 & 2032 (%)
    • 10.1.2. Intravenous (IV)
    • 10.1.3. Subcutaneous
    • 10.1.4. Oral
    • 10.1.5. Intramuscular

11. Immunotherapy Drugs Market - By End User

  • 11.1. Overview
    • 11.1.1. Segment Share Analysis, By End User, 2023 & 2032 (%)
    • 11.1.2. Hospitals
    • 11.1.3. Clinics
    • 11.1.4. Cancer Research Centers
    • 11.1.5. Ambulatory Surgical Centers
    • 11.1.6. Homecare Settings

12. Immunotherapy Drugs Market- By Geography

  • 12.1. Introduction
    • 12.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 12.2. North America
    • 12.2.1. Overview
    • 12.2.2. Immunotherapy Drugs Key Manufacturers in North America
    • 12.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.2.4. North America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 12.2.5. North America Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 12.2.6. North America Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
    • 12.2.7. North America Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 12.2.8. North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.2.9. U.S.
      • 12.2.9.1. Overview
      • 12.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.2.9.3. U.S. Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 12.2.9.4. U.S. Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.2.9.5. U.S. Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 12.2.9.6. U.S. Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.2.9.7. U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.2.10. Canada
      • 12.2.10.1. Overview
      • 12.2.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.2.10.3. Canada Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 12.2.10.4. Canada Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.2.10.5. Canada Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 12.2.10.6. Canada Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.2.10.7. Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 12.3. Europe
    • 12.3.1. Overview
    • 12.3.2. Immunotherapy Drugs Key Manufacturers in Europe
    • 12.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.3.4. Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 12.3.5. Europe Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 12.3.6. Europe Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
    • 12.3.7. Europe Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 12.3.8. Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.9. Germany
      • 12.3.9.1. Overview
      • 12.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.9.3. Germany Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 12.3.9.4. Germany Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.3.9.5. Germany Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 12.3.9.6. Germany Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.3.9.7. Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.10. Italy
      • 12.3.10.1. Overview
      • 12.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.10.3. Italy Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 12.3.10.4. Italy Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.3.10.5. Italy Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 12.3.10.6. Italy Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.3.10.7. Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.11. United Kingdom
      • 12.3.11.1. Overview
      • 12.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.11.3. United Kingdom Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 12.3.11.4. United Kingdom Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.3.11.5. United Kingdom Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 12.3.11.6. United Kingdom Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.3.11.7. United Kingdom Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.12. France
      • 12.3.12.1. Overview
      • 12.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.12.3. France Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 12.3.12.4. France Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.3.12.5. France Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 12.3.12.6. France Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.3.12.7. France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.13. Russia
      • 12.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.13.2. Russia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 12.3.13.3. Russia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.3.13.4. Russia Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 12.3.13.5. Russia Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.3.13.6. Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.14. Netherlands
      • 12.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.14.2. Netherlands Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 12.3.14.3. Netherlands Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.3.14.4. Netherlands Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 12.3.14.5. Netherlands Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.3.14.6. Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.15. Sweden
      • 12.3.15.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.15.2. Sweden Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 12.3.15.3. Sweden Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.3.15.4. Sweden Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 12.3.15.5. Sweden Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.3.15.6. Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.16. Poland
      • 12.3.16.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.16.2. Poland Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 12.3.16.3. Poland Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.3.16.4. Poland Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 12.3.16.5. Poland Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.3.16.6. Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.17. Rest of Europe
      • 12.3.17.1. Overview
      • 12.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.17.3. Rest of the Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 12.3.17.4. Rest of the Europe Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.3.17.5. Rest of the Europe Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 12.3.17.6. Rest of the Europe Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.3.17.7. Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 12.4. Asia Pacific (APAC)
    • 12.4.1. Overview
    • 12.4.2. Immunotherapy Drugs Key Manufacturers in Asia Pacific
    • 12.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.4.4. Asia Pacific Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 12.4.5. Asia Pacific Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 12.4.6. Asia Pacific Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
    • 12.4.7. Asia Pacific Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 12.4.8. Asia Pacific Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.9. India
      • 12.4.9.1. Overview
      • 12.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.9.3. India Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 12.4.9.4. India Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.4.9.5. India Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 12.4.9.6. India Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.4.9.7. India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.10. China
      • 12.4.10.1. Overview
      • 12.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.10.3. China Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 12.4.10.4. China Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.4.10.5. China Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 12.4.10.6. China Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.4.10.7. China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.11. Japan
      • 12.4.11.1. Overview
      • 12.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.11.3. Japan Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 12.4.11.4. Japan Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.4.11.5. Japan Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 12.4.11.6. Japan Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.4.11.7. Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.12. South Korea
      • 12.4.12.1. Overview
      • 12.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.12.3. South Korea Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 12.4.12.4. South Korea Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.4.12.5. South Korea Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 12.4.12.6. South Korea Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.4.12.7. South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.13. Australia
      • 12.4.13.1. Overview
      • 12.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.13.3. Australia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 12.4.13.4. Australia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.4.13.5. Australia Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 12.4.13.6. Australia Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.4.13.7. Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.14. Thailand
      • 12.4.14.1. Overview
      • 12.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.14.3. Thailand Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 12.4.14.4. Thailand Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.4.14.5. Thailand Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 12.4.14.6. Thailand Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.4.14.7. Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.15. Indonesia
      • 12.4.15.1. Overview
      • 12.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.15.3. Indonesia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 12.4.15.4. Indonesia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.4.15.5. Indonesia Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 12.4.15.6. Indonesia Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.4.15.7. Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.16. Philippines
      • 12.4.16.1. Overview
      • 12.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.16.3. Philippines Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 12.4.16.4. Philippines Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.4.16.5. Philippines Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 12.4.16.6. Philippines Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.4.16.7. Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.17. Rest of APAC
      • 12.4.17.1. Overview
      • 12.4.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.17.3. Rest of APAC Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 12.4.17.4. Rest of APAC Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.4.17.5. Rest of APAC Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 12.4.17.6. Rest of APAC Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.4.17.7. Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 12.5. Latin America
    • 12.5.1. Overview
    • 12.5.2. Immunotherapy Drugs Key Manufacturers in Latin America
    • 12.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.5.4. Latin America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 12.5.5. Latin America Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 12.5.6. Latin America Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
    • 12.5.7. Latin America Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 12.5.8. Latin America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.5.9. Brazil
      • 12.5.9.1. Overview
      • 12.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.9.3. Brazil Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 12.5.9.4. Brazil Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.5.9.5. Brazil Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 12.5.9.6. Brazil Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.5.9.7. Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.5.10. Mexico
      • 12.5.10.1. Overview
      • 12.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.10.3. Mexico Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 12.5.10.4. Mexico Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.5.10.5. Mexico Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 12.5.10.6. Mexico Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.5.10.7. Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.5.11. Argentina
      • 12.5.11.1. Overview
      • 12.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.11.3. Argentina Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 12.5.11.4. Argentina Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.5.11.5. Argentina Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 12.5.11.6. Argentina Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.5.11.7. Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.5.12. Colombia
      • 12.5.12.1. Overview
      • 12.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.12.3. Colombia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 12.5.12.4. Colombia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.5.12.5. Colombia Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 12.5.12.6. Colombia Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.5.12.7. Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.5.13. Rest of LATAM
      • 12.5.13.1. Overview
      • 12.5.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.13.3. Rest of LATAM Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 12.5.13.4. Rest of LATAM Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.5.13.5. Rest of LATAM Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 12.5.13.6. Rest of LATAM Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.5.13.7. Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 12.6. Middle East and Africa
    • 12.6.1. Overview
    • 12.6.2. Immunotherapy Drugs Key Manufacturers in Middle East and Africa
    • 12.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.6.4. Middle East and Africa Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 12.6.5. Middle East and Africa Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 12.6.6. Middle East and Africa Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
    • 12.6.7. Middle East and Africa Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 12.6.8. Middle East and Africa Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.9. Saudi Arabia
      • 12.6.9.1. Overview
      • 12.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.9.3. Saudi Arabia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 12.6.9.4. Saudi Arabia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.6.9.5. Saudi Arabia Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 12.6.9.6. Saudi Arabia Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.6.9.7. Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.10. United Arab Emirates
      • 12.6.10.1. Overview
      • 12.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.10.3. United Arab Emirates Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 12.6.10.4. United Arab Emirates Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.6.10.5. United Arab Emirates Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 12.6.10.6. United Arab Emirates Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.6.10.7. United Arab Emirates Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.11. Israel
      • 12.6.11.1. Overview
      • 12.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.11.3. Israel Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 12.6.11.4. Israel Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.6.11.5. Israel Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 12.6.11.6. Israel Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.6.11.7. Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.12. Turkey
      • 12.6.12.1. Overview
      • 12.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.12.3. Turkey Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 12.6.12.4. Turkey Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.6.12.5. Turkey Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 12.6.12.6. Turkey Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.6.12.7. Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.13. Algeria
      • 12.6.13.1. Overview
      • 12.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.13.3. Algeria Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 12.6.13.4. Algeria Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.6.13.5. Algeria Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 12.6.13.6. Algeria Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.6.13.7. Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.14. Egypt
      • 12.6.14.1. Overview
      • 12.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.14.3. Egypt Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 12.6.14.4. Egypt Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.6.14.5. Egypt Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 12.6.14.6. Egypt Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.6.14.7. Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.15. Rest of MEA
      • 12.6.15.1. Overview
      • 12.6.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.15.3. Rest of MEA Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 12.6.15.4. Rest of MEA Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.6.15.5. Rest of MEA Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 12.6.15.6. Rest of MEA Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.6.15.7. Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)

13. Key Vendor Analysis- Immunotherapy Drugs Industry

  • 13.1. Competitive Dashboard
  • 13.2. Company Profiles
    • 13.2.1. Bristol-Myers Squibb
    • 13.2.2. Merck & Co.
    • 13.2.3. Roche
    • 13.2.4. Pfizer
    • 13.2.5. Novartis
    • 13.2.6. Gilead Sciences
    • 13.2.7. Amgen
    • 13.2.8. Sanofi
    • 13.2.9. Regeneron Pharmaceuticals
    • 13.2.10. Bluebird Bio
    • 13.2.11. Cellectis
    • 13.2.12. Others

14. 360 Degree Analyst View

15. Appendix

  • 15.1. Research Methodology
  • 15.2. References
  • 15.3. Abbreviations
  • 15.4. Disclaimer
  • 15.5. Contact Us

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Immunotherapy Drugs Market: Type Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Type
  • TABLE Global Immunotherapy Drugs Market, by Type 2019-2032 (USD Million)
  • TABLE Immunotherapy Drugs Market: Product Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Product
  • TABLE Global Immunotherapy Drugs Market, by Product 2019-2032 (USD Million)
  • TABLE Immunotherapy Drugs Market: Distribution Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Distribution
  • TABLE Global Immunotherapy Drugs Market, by Distribution 2019-2032 (USD Million)
  • TABLE Immunotherapy Drugs Market: Route of Administration Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Route of Administration
  • TABLE Global Immunotherapy Drugs Market, by Route of Administration 2019-2032 (USD Million)
  • TABLE Immunotherapy Drugs Market: End User Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by End User
  • TABLE Global Immunotherapy Drugs Market, by End User 2019-2032 (USD Million)
  • TABLE Immunotherapy Drugs Market: Regional snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Immunotherapy Drugs Market, by Region 2019-2032 (USD Million)
  • TABLE North America Immunotherapy Drugs Market, by Country, 2019-2032 (USD Million)
  • TABLE North America Immunotherapy Drugs Market, by Type, 2019-2032 (USD Million)
  • TABLE North America Immunotherapy Drugs Market, by Product, 2019-2032 (USD Million)
  • TABLE North America Immunotherapy Drugs Market, by Distribution, 2019-2032 (USD Million)
  • TABLE North America Immunotherapy Drugs Market, by Route of Administration, 2019-2032 (USD Million)
  • TABLE North America Immunotherapy Drugs Market, by End User, 2019-2032 (USD Million)
  • TABLE Europe Immunotherapy Drugs Market, by Country, 2019-2032 (USD Million)
  • TABLE Europe Immunotherapy Drugs Market, by Type, 2019-2032 (USD Million)
  • TABLE Europe Immunotherapy Drugs Market, by Product, 2019-2032 (USD Million)
  • TABLE Europe Immunotherapy Drugs Market, by Distribution, 2019-2032 (USD Million)
  • TABLE Europe Immunotherapy Drugs Market, by Route of Administration, 2019-2032 (USD Million)
  • TABLE Europe Immunotherapy Drugs Market, by End User, 2019-2032 (USD Million)
  • TABLE Asia Pacific Immunotherapy Drugs Market, by Country, 2019-2032 (USD Million)
  • TABLE Asia Pacific Immunotherapy Drugs Market, by Type, 2019-2032 (USD Million)
  • TABLE Asia Pacific Immunotherapy Drugs Market, by Product, 2019-2032 (USD Million)
  • TABLE Asia Pacific Immunotherapy Drugs Market, by Distribution, 2019-2032 (USD Million)
  • TABLE Asia Pacific Immunotherapy Drugs Market, by Route of Administration, 2019-2032 (USD Million)
  • TABLE Asia Pacific Immunotherapy Drugs Market, by End User, 2019-2032 (USD Million)
  • TABLE Latin America Immunotherapy Drugs Market, by Country, 2019-2032 (USD Million)
  • TABLE Latin America Immunotherapy Drugs Market, by Type, 2019-2032 (USD Million)
  • TABLE Latin America Immunotherapy Drugs Market, by Product, 2019-2032 (USD Million)
  • TABLE Latin America Immunotherapy Drugs Market, by Distribution, 2019-2032 (USD Million)
  • TABLE Latin America Immunotherapy Drugs Market, by Route of Administration, 2019-2032 (USD Million)
  • TABLE Latin America Immunotherapy Drugs Market, by End User, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Immunotherapy Drugs Market, by Country, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Immunotherapy Drugs Market, by Type, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Immunotherapy Drugs Market, by Product, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Immunotherapy Drugs Market, by Distribution, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Immunotherapy Drugs Market, by Route of Administration, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Immunotherapy Drugs Market, by End User, 2019-2032 (USD Million)

List of Figures

  • FIGURE Immunotherapy Drugs Market Segmentation
  • FIGURE Market research methodology
  • FIGURE Value chain analysis
  • FIGURE Porter's Five Forces Analysis
  • FIGURE Market Attractiveness Analysis
  • FIGURE COVID-19 Impact Analysis
  • FIGURE Pre & Post COVID-19 Impact Comparision Study
  • FIGURE Competitive Landscape; Key company market share analysis, 2023
  • FIGURE Type segment market share analysis, 2023 & 2032
  • FIGURE Type segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Product segment market share analysis, 2023 & 2032
  • FIGURE Product segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Distribution segment market share analysis, 2023 & 2032
  • FIGURE Distribution segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Route of Administration segment market share analysis, 2023 & 2032
  • FIGURE Route of Administration segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE End User segment market share analysis, 2023 & 2032
  • FIGURE End User segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Regional segment market share analysis, 2023 & 2032
  • FIGURE Regional segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE North America Immunotherapy Drugs Market share and leading players, 2023
  • FIGURE Europe Immunotherapy Drugs Market share and leading players, 2023
  • FIGURE Asia Pacific Immunotherapy Drugs Market share and leading players, 2023
  • FIGURE Latin America Immunotherapy Drugs Market share and leading players, 2023
  • FIGURE Middle East and Africa Immunotherapy Drugs Market share and leading players, 2023
  • FIGURE North America market share analysis by country, 2023
  • FIGURE U.S. Immunotherapy Drugs Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Canada Immunotherapy Drugs Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Europe Immunotherapy Drugs Market share analysis by country, 2023
  • FIGURE Germany Immunotherapy Drugs Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Spain Immunotherapy Drugs Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Italy Immunotherapy Drugs Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE France Immunotherapy Drugs Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE UK Immunotherapy Drugs Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Russia Immunotherapy Drugs Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Netherlands Immunotherapy Drugs Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Sweden Immunotherapy Drugs Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Poland Immunotherapy Drugs Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of the Europe Immunotherapy Drugs Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Asia Pacific Immunotherapy Drugs Market share analysis by country, 2023
  • FIGURE India Immunotherapy Drugs Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE China Immunotherapy Drugs Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Japan Immunotherapy Drugs Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE South Korea Immunotherapy Drugs Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Australia Immunotherapy Drugs Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Thailand Immunotherapy Drugs Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Indonesia Immunotherapy Drugs Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Philippines Immunotherapy Drugs Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of APAC Immunotherapy Drugs Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Latin America Immunotherapy Drugs Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Latin America Immunotherapy Drugs Market share analysis by country, 2023
  • FIGURE Brazil Immunotherapy Drugs Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Mexico Immunotherapy Drugs Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Argentina Immunotherapy Drugs Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Colombia Immunotherapy Drugs Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of LATAM Immunotherapy Drugs Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Middle East and Africa Immunotherapy Drugs Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Middle East and Africa Immunotherapy Drugs Market share analysis by country, 2023
  • FIGURE Saudi Arabia Immunotherapy Drugs Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE United Arab Emirates Immunotherapy Drugs Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Israel Immunotherapy Drugs Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Turkey Immunotherapy Drugs Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Algeria Immunotherapy Drugs Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Egypt Immunotherapy Drugs Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of MEA Immunotherapy Drugs Market size, forecast and trend analysis, 2019 to 2032 (USD Million)